For kidney transplant recipients with type 2 diabetes, use of glucagon-like peptide-1 receptor agonists was associated with ...

By screening people for eating disorders and disordered eating before these medications are prescribed, we can prevent unintended consequences.

Stopping GLP-1 receptor agonists 14 days prior to total hip or knee arthroplasty may reduce several key risk factors ...

Vivani Medical (Nasdaq:VANI) announced today that it successfully administered the first GLP-1 implant in its LIBERATE-1 ...

GLP-1 receptor agonists (GLP-1RAs ... the protective group is removed when the subsequent amino acid is added to the sequence, along with a coupling reagent that forms an amide bond between ...

Feb. 12, 2024 – People with type 2 diabetes taking GLP-1 medicines may experience potentially blinding eye conditions as soon as the day after starting the drugs, and eye doctors are now asking ...

However, for crude incidence rates there was an increased incidence of suicidality with GLP-1 receptor agonist vs DPP-4 inhibitor use; 3.9 vs 1.8 per 1000 person-years. HealthDay News — Glucagon ...

The sudden rise of GLP-1 drugs is also seen as an opportunity ... It also made a $100 million-plus deal to buy Sequence, a telehealth business that offers virtual prescriptions to patients for ...

When Trova Wine and Market shut its doors last month after nearly five years in Dallas, owner Michelle Bonds pointed to an unexpected reason for closure: GLP-1 weight loss drugs like Ozempic.

Glucagon-like peptide-1 receptor agonists (GLP-1) drugs are a class of medications used to manage type 2 diabetes and treat obesity. While many drugs in this class are relatively new, researchers ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Patients using GLP-1 drugs had no difference in the odds of postoperative aspiration pneumonia versus non-users.